Science Purposes Worldwide Company (SAIC) This autumn 2026 Earnings Name March 16, 2026 10:00 AM EDT
Firm Contributors
Jon Therapeutic
James Reagan – CEO & Director
Prabu Natarajan – Government VP & CFO
Convention Name Contributors
Jeremy Jason – Citigroup Inc., Analysis Division
Sebastian Rivera – Stifel, Nicolaus & Firm, Included, Analysis Division
Gavin Parsons – UBS Funding Financial institution, Analysis Division
Sheila Kahyaoglu – Jefferies LLC, Analysis Division
Gautam Khanna – TD Cowen, Analysis Division
Colin Canfield – Cantor Fitzgerald & Co., Analysis Division
Tobey Sommer – Truist Securities, Inc., Analysis Division
Noah Poponak – Goldman Sachs Group, Inc., Analysis Division
Presentation
Operator
Good day, and thanks for standing by. Welcome to SAIC’s Fourth Quarter Fiscal 12 months 2026 Earnings Name. (Operator Directions). Please be suggested that right this moment’s convention is being recorded.
I would now like handy the convention over to Jon Raviv, Vice President of Investor Relations. Please go forward.
Jon Therapeutic
Good morning, and thanks for becoming a member of SAIC’s Fourth Quarter Fiscal 12 months 2026 Earnings Name. My identify is Jon Raviv, Vice President of Investor Relations, and becoming a member of me right this moment to debate our enterprise and monetary outcomes are Jim Reagan, our Chief Government Officer; and Prabu Natarajan, our Chief Monetary Officer. Immediately, we are going to focus on our outcomes for the quarter that ended January 30.
Please be aware that we could make forward-looking statements on right this moment’s name which can be topic to identified and unknown dangers and uncertainties that would trigger precise outcomes to vary materially from statements made on this name. I refer you to our SEC filings for a dialogue of those dangers. As well as, we are going to focus on non-GAAP monetary measures and different metrics, which we consider present helpful data for buyers. These non-GAAP measures must be thought-about along with and never an alternative to monetary measures in accordance with GAAP. A extra fulsome clarification of those measures will also be